Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockade-Reference-Cited by-同舟云学术

Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockade

Published:2023-01 Issue: Volume:66 Page:100907
ISSN:1368-7646
Container-title:Drug Resistance Updates
language:en
Short-container-title:Drug Resistance Updates

Author:

Pang Kun,Shi Zhen-Duo,Wei Liu-Ya,Dong Yang,Ma Yu-Yang,Wang Wei,Wang Guang-Yue,Cao Ming-Yang,Dong Jia-Jun,Chen Yu-Ang,Zhang Peng,Hao Lin,Xu Hao,Pan Deng,Chen Zhe-Sheng^ORCID,Han Cong-Hui

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Cancer Research,Pharmacology,Oncology

Reference169 articles.

1. New cancer immunotherapy agents in development: a report from an associated program of the 31(st)Annual Meeting of the Society for Immunotherapy of Cancer, 2016;Adusumilli;J. Immunother. Cancer,2017

2. Neoadjuvant treatment in non-small cell lung cancer: new perspectives with the incorporation of immunotherapy;Aguado;World J. Clin. Oncol.,2022

3. Transcriptional reprogramming and constitutive PD-L1 expression in melanoma are associated with dedifferentiation and activation of interferon and tumour necrosis factor signalling pathways;Ahn;Cancers (Basel),2021

4. Roles of PD-1/PD-L1 pathway: signaling, cancer, and beyond;Ai;Adv. Exp. Med Biol.,2020

5. Pembrolizumab for the treatment of Hodgkin Lymphoma;Al Hadidi;Expert Opin. Biol. Ther.,2020

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-derived exosomal ICAM1 promotes bone metastasis of triple-negative breast cancer by inducing CD8+ T cell exhaustion;The International Journal of Biochemistry & Cell Biology;2024-10

2. Infiltrating treg reprogramming in the tumor immune microenvironment and its optimization for immunotherapy;Biomarker Research;2024-09-04

3. Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers : the “all-around warrior” in immunotherapy;Molecular Cancer;2024-09-02

4. Multi-omics landscape of Interferon-stimulated gene OASL reveals a potential biomarker in pan-cancer: from prognosis to tumor microenvironment;Frontiers in Immunology;2024-09-02

5. Immunostimulatory CKb11 gene combined with immune checkpoint PD-1/PD-L1 blockade activates immune response and simultaneously overcomes the immunosuppression of cancer;Bioactive Materials;2024-09